Vaishampayan UN, Thakur A, Chen W, Deol A, et al. Phase II trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody Armed Activated T Cells in Metastatic Castrate Resistant Prostate Cancer. Clin Cancer Res 2022 Oct 18. pii: 709809. doi: 10.1158/1078-0432.CCR-22-1601.
PMID: 36255393